← Evidence map

ArticleMolecular cancer2023

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer.

Fei Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

39 papers cite it

2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36627608